Famicare Speciality Center

NK cell Therapy

Natural Killer (NK) cells, T regulatory (Treg) cells, and Cytokine-Induced Killer (CIK) cells represent crucial components of the immune system that hold immense potential in the fight against cancer. This essay explores the roles of these immune cells and their promising contributions to cancer treatment and cure.

Natural Killer (NK) Cells:

NK cells are a type of lymphocyte that plays a pivotal role in the body’s innate immune response against cancer and infected cells. These cells are equipped with the ability to recognize and destroy abnormal cells without prior sensitization or specific antigen recognition.

NK Cells in Cancer Treatment

• NK cells are known for their ability to target and eliminate cancer cells directly through mechanisms such as perforin-mediated cell lysis and the release of cytotoxic molecules.
• They play a crucial role in immune surveillance, identifying and eliminating cancerous cells before they develop into tumors or metastasize.
• NK cell therapy involves enhancing the activity of these cells through techniques such as cytokine stimulation or adoptive cell transfer, offering a promising avenue for cancer immunotherapy.

Treg cells & Cancer Treatment

Treg cells are a specialized subset of T lymphocytes known for their regulatory function in immune tolerance and suppression of excessive immune responses. While their role in cancer can be complex, they are being studied extensively for their potential impact on cancer treatment strategies.

Role in Cancer Treatment:

• Treg cells can suppress anti-tumor immune responses, contributing to immune evasion by cancer cells. However, modulating Treg cell activity presents opportunities for enhancing anti-tumor immune responses.
• Strategies such as Treg cell depletion or inhibition are being explored to overcome immunosuppression in the tumor microenvironment and enhance the efficacy of cancer immunotherapy approaches.

Cytokine-Induced Killer (CIK) Cells

• CIK cells are a type of immune cell generated from peripheral blood lymphocytes that have been activated and expanded ex vivo. These cells exhibit potent anti-tumor activity and have garnered interest as a cellular therapy for cancer.

Role in Cancer Treatment:

• CIK cells possess cytotoxic capabilities similar to NK cells and T lymphocytes, making them effective in targeting and killing cancer cells.
• CIK cell therapy involves isolating and expanding patient-derived CIK cells in the laboratory before reinfusing them into the patient, enhancing the body’s immune response against cancer.
• Clinical studies have shown promising results with CIK cell therapy, particularly in treating hematological malignancies and solid tumors.

Combination of NK cells, Treg cell modulation & CIK cell therapy

• The combination of NK cells, Treg cell modulation, and CIK cell therapy represents a multifaceted approach to cancer treatment and potential cure.
• Targeting cancer cells directly with NK and CIK cells.
• Modulating immune tolerance and enhancing anti-tumor immunity by regulating Treg cell activity.
• Offering personalized and immunologically targeted therapies that harness the body’s immune defenses against cancer.